Volcano Corp. blew away analysts' forecasts for the 4th quarter and full-year 2011, but aims low for this year.
Volcano Corp. (NSDQ:VOLC) blew away analysts' expectations for the 4th quarter and 2011, but lost some love on Wall Street over its low guidance for 2012.
The San Diego-based company reported a 14% bump in sales to $92.7 million, compared to $81.2 million for the same period in 2010, and $29.4 million in profit, compared to a loss of $1.7 million during Q4 2010. That translates to 54 cents EPS – 14 cents EPS on an adjusted basis, nearly triple analysts' expectations of 5 cents apiece.
Volcano raked in $343.5 million in revenues for 2011, a 17% jump over $294.1 million in 2010, driven by a 23% bump for its medical products segment. Volcano's industrial segment posted a 52% sales decline.
Full-year earnings soared to $38.1 million, or 70 cents per diluted share, up a whopping 633% over $5.2 million, or 10 cents per diluted share, during 2010.
Although adjusted EPS for 2011 was bolstered by 40 cents due to the release of a portion of the company's deferred tax valuation allowance in the 4th quarter, adjusted EPS of 30 cents still beat analysts' full-year expectations of 21 cents.
Volcano attributed the spike primarily to a 37% bump in fractional flow reserve disposable revenues and an equally significant 19% jump in intravascular ultrasound disposable revenues.
The company forecast its 2012 earnings in the range of $392 million to $399 million, or 21-24 cents EPS, falling short of analysts' prediction of 30 cents for next year.
VOLC shares slid a bit on The Street following its after-market-close release. Shares opened at $25.52 this morning before regaining ground to trade at $27.87 as of about 1:00 p.m. today – still a 1% drop from last night's $28.18 close.
Manny Villafana, who founded St. Jude Medical and Kips Bay Medical, joins a last-gasp, $3 million...
Johnson & Johnson inks a deal with Google to develop a robot-assisted surgery device.
Cardica says it will lay off about 24% of its workforce in a bid to conserve cash as it tries to get...
ReWalk Robotics plans to launch its wearable robotic exoskeleton device in India by the 2nd quarter...
Royal Philips wins another year on its $77 million contract with the U.S. Defense Dept. for patient...